|
Risk factor
|
Number of patients in PICC group (n = 20)
|
Number of patients in LTSTC group (n = 4)
|
|---|
|
Known background of inherited prothrombotic conditions (%)
|
0 (0)
|
0 (0)
|
|
History of VTE or PE (%)
|
2 (10)
|
0 (0)
|
|
Chemotherapy administered (%):
| | |
|
Immunomodulatory drug
|
2 (10)
|
2 (10)
|
|
Hormonal therapy
|
0 (0)
|
0 (0)
|
|
Anti-platelet therapy (%)
|
0 (0)
|
0 (0)
|
|
Anti-coagulant prophylaxis (LMWH) (%)
|
2 (10)
|
2 (10)
|
- NB: PICC = Peripherally-Inserted Central Venous Catheter; LTSTC = Long Term Skin Tunneled Catheter; VTE = Venous Thromboembolism; PE = Pulmonary Embolism; LMWH = Low-Molecular Weight Heparin.